Medi-cygne: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Medi-cygne
Largest movements
- Cash +€178,690
up €178,690 (+133%), from €133,999 to €312,689
mainly Net result for the year (+€112,880) and Current investments (+€49,586)
- Current investments -€49,586
down €49,586 (-19.3%), from €256,650 to €207,064
- Profit (loss) carried forward +€112,880
up €112,880 (+29.6%), from €381,197 to €494,077
- Other debts +€15,723
up €15,723 (+50.2%), from €31,353 to €47,076
- Gross operating margin -€2,848
down €2,848 (-2.0%), from €144,185 to €141,337
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €419,181 | €546,771 | +€127,589 | +30.4% |
| Fixed assets | 21/28 | €600 | €931 | +€331 | +55.1% |
| Tangible fixed assets | 22/27 | €600 | €931 | +€331 | +55.1% |
| Plant, machinery and equipment | 23 | €380 | €931 | +€551 | +145% |
| Furniture and vehicles | 24 | €221 | - | -€221 | |
| Current assets | 29/58 | €418,581 | €545,839 | +€127,258 | +30.4% |
| Amounts receivable within one year | 40/41 | €25,328 | €23,915 | -€1,413 | -5.6% |
| Other amounts receivable | 41 | €25,328 | €23,915 | -€1,413 | -5.6% |
| Current investments | 50/53 | €256,650 | €207,064 | -€49,586 | -19.3% |
| Cash at bank and in hand | 54/58 | €133,999 | €312,689 | +€178,690 | +133% |
| Deferred charges and accrued income | 490/1 | €2,603 | €2,171 | -€433 | -16.6% |
| Total equity and liabilities | 10/49 | €419,181 | €546,771 | +€127,589 | +30.4% |
| Equity | 10/15 | €385,197 | €498,077 | +€112,880 | +29.3% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €381,197 | €494,077 | +€112,880 | +29.6% |
| Amounts payable | 17/49 | €33,984 | €48,694 | +€14,710 | +43.3% |
| Amounts payable within one year | 42/48 | €33,984 | €48,694 | +€14,710 | +43.3% |
| Trade debts | 44 | €1,641 | €1,617 | -€23 | -1.4% |
| Suppliers | 440/4 | €1,641 | €1,617 | -€23 | -1.4% |
| Taxes, remuneration and social security | 45 | €991 | - | -€991 | |
| Taxes | 450/3 | €991 | - | -€991 | |
| Other amounts payable | 47/48 | €31,353 | €47,076 | +€15,723 | +50.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €714 | €655 | -€59 | -8.3% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €144,185 | €141,337 | -€2,848 | -2.0% |
| Operating profit (loss) | 9901 | €143,084 | €140,283 | -€2,801 | -2.0% |
| Financial income | 75/76B | €4,431 | €4,320 | -€112 | -2.5% |
| Recurring financial income | 75 | €4,431 | €4,320 | -€112 | -2.5% |
| Financial charges | 65/66B | €15 | €93 | +€78 | +509% |
| Recurring financial charges | 65 | €15 | €93 | +€78 | +509% |
| Profit (loss) for the period before taxes | 9903 | €147,500 | €144,510 | -€2,990 | -2.0% |
| Income taxes | 67/77 | €32,298 | €31,630 | -€668 | -2.1% |
| Profit (loss) for the period | 9904 | €115,202 | €112,880 | -€2,323 | -2.0% |
| Profit (loss) for the period to be appropriated | 9905 | €115,202 | €112,880 | -€2,323 | -2.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.